Reproducibility in biological models of the blood-brain barrier

European Journal of Nanomedicine

Volumn 6, Issue 3, 2014, Pages 185-193

  Hudecz, Diána ^a   Rocks, Louise ^a   Fitzpatrick, Laurence W ^a   Herda, Luciana Maria ^a   Dawson, Kenneth A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

blood brain barrier; in vitro; live cell imaging; nanoparticle; reproducibility; transcytosis

Indexed keywords

CONTROLLED DRUG DELIVERY; COST EFFECTIVENESS; NANOPARTICLES; NEURODEGENERATIVE DISEASES; TARGETED DRUG DELIVERY;

BLOOD-BRAIN BARRIER; IN-VITRO; LIVE-CELL IMAGING; REPRODUCIBILITIES; TRANSCYTOSIS;

BLOOD;

COLLAGEN; FIBRONECTIN; FLUORESCENT DYE; NANOPARTICLE;

BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; BLOOD FLOW; BRAIN CAPILLARY ENDOTHELIAL CELL; COCULTURE; CONFOCAL MICROSCOPY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENERGY TRANSFER; EXOCYTOSIS; FILTERS AND MEMBRANES; FLUORESCENCE MICROSCOPY; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROFLUIDICS; MICROVASCULATURE; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; REPRODUCIBILITY; REVIEW; SHEAR STRESS; TRANSCYTOSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84907525368     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2014-0021     Document Type: Review

References (65)

1. Challenges in Irreproducible Research. Nature Special. [cited 2014 May 1]. Available from: http://www.nature.com/nature/focus/reproducibility/.
2. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008;105:14265-70.
3. Monopoli MP, Aberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol. Nature Publishing Group; 2012;7:779-86.
4. Hole P, Sillence K, Hannell C, Maguire CM, Roesslein M, Suarez G, et al. Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA). J Nanopart Res 2013;15:2101.
5. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005;19:311-30.
6. Masserini M. Nanoparticles for Brain Drug Delivery. ISRN Biochem 2013;2013:1-18.
7. Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? Adv Drug Deliv Rev 2014;71:2-14.
8. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37:13-25.
9. Abbott NJ. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 2013;36:437-49.
10. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53.
11. Fishman JB, Rubin JB, Handrahan J V, Connor JR, Fine RE. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res 1987;18:299-304.
12. Banks WA, Jaspan JB, Kastin AJ. Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides 1997;18:1257-62.
13. Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides 1997;18:1423-9.
14. Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R. A new function for the LDL receptor: Transcytosis of LDL across the blood-brain barrier. J Cell Biol 1997;138:877-89.
15. Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Wagner S, et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release 2009;137:78-86.
16. Zensi A, Begley D, Pontikis C, Legros C, Mihoreanu L, Büchel C, et al. Human serum albumin nanoparticles modified with apolipoprotein A-I cross the blood-brain barrier and enter the rodent brain. J Drug Target 2010;18:842-8.
17. Wagner S, Zensi A, Wien SL, Tschickardt SE, Maier W, Vogel T, et al. Uptake Mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS One. Public Library of Science; 2012;7:e32568.
18. Ye D, Raghnaill MN, Bramini M, Mahon E, Aberg C, Salvati A, et al. Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Nanoscale 2013;5:11153-65.
19. Sandin P, Fitzpatrick LW, Simpson JC, Dawson KA. High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS Nano 2012;6:1513-21.
20. Bertoli F, Davies G-L, Monopoli MP, Moloney M, Gunko YK, Salvati A, et al. Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake. Small 2014; Available from: http://onlinelibrary.wiley.com/doi/10.1002/smll.201303841/abstract; doi: 10.1002/smll.201303841.
21. Ma D. Enhancing endosomal escape for nanoparticle mediated siRNA delivery. Nanoscale 2014;6:6415-25.
22. Nowak JS, Mehn D, Nativo P, García CP, Gioria S, Ojea-Jiménez I, et al. Silica nanoparticle uptake induces survival mechanism in A549 cells by the activation of autophagy but not apoptosis. Toxicol Lett 2014;224:84-92.
23. Abbott NJ, Dolman DE, Yusof SR, Reichel A. In Vitro models of CNS barriers. In: Hammarlund-Udenaes M, de Lange ECM, Thorne RG, editors. Drug Delivery to the Brain, AAPS Advances in the Pharmaceutical Sciences Series. New York: Springer; 2014 p. 163-97.
24. Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood-brain barrier. Eur J Med Chem 2003;38:223-32.
25. Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, et al. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol. Nature Publishing Group; 2012;30:783-91.
26. Lippmann ES, Al-Ahmad A, Palecek SP, Shusta EV. Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS. Fluids and Barriers of the CNS; 2013;10:2.
27. Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep 2014;4:4160.
28. Bicker J, Alves G, Fortuna A, Falcão A. Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review. Eur J Pharm Piopharmaceutics 2014;87:409-32.
29. Wilhelm I, Krizbai IA. In vitro models of the blood-brain barrier for the study of drug delivery to the brain. Mol Pharm 2014;11:1949-63.
30. Roux F, Durieu-Trautmann O, Chaverot N, Claire M, Mailly P, Bourre J-M, et al. Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 1994;159:101-13.
31. Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 2009;54:253-63.
32. Terasaki T, Hosoya K. Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biol Pharm Bull 2001;24:111-8.
33. Abbott NJ, Dolman DM, Drndarski S, Fredriksson S. An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. Methods Mol Biol 2012;814:415-30.
34. Williams RL, Courtneidge SA, Wagner EF. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 1988;52:121-31.
35. Williams RL, Risau W, Zerwes H-G, Drexler H, Aguzzi A, Wagner EF. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 1989;57:1053-63.
36. Bowman PD, Ennis SR, Rarey KE, Lorris Betz A, Goldstein GW. Brain microvessel endothelial cells in tissue culture: A model for study of blood-brain barrier permeability. Ann Neurol. Little, Brown and Company; 1983;14:396-402.
37. Rubin H, Xu K. Evidence for the progressive and adaptive nature of spontaneous transformation in the NIH 3T3 cell line. Proc Natl Acad Sci 1989;86:1860-4.
38. Patabendige A, Skinner RA, Abbott NJ. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res 2013;1521:1-15.
39. Weksler BB, Subileau EA, Perrire N, Charneau P, Holloway K, Leveque M, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005;19:1872-4.
40. Stins MF, Badger J, Sik Kim K. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb Pathog 2001;30:19-28.
41. Sano Y, Shimizu F, Abe M, Maeda T, Kashiwamura Y, Ohtsuki S, et al. Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function. J Cell Physiol 2010;225:519-28.
42. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood-brain barrier. Nature 2010;468:557-61.
43. Avdeef A. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Eur J Pharm Sci 2011;43:109-24.
44. Ragnaill MN, Brown M, Ye D, Bramini M, Callanan S, Lynch I, et al. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. Eur J Pharm Biopharm 2011;77:360-7.
45. Bramini M, Ye D, Hallerbach A, Nic Raghnaill M, Salvati A, Aberg C, et al. Imaging approach to mechanistic study of nanoparticle interactions. ACS Nano 2014;8:4304-12.
46. Gromnicova R, Davies HA, Sreekanthreddy P, Romero IA, Lund T, Roitt IM, et al. Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS One 2013;8:e81043.
47. Eugenin EA, Clements JE, Zink MC, Berman JW. Human immunodeficiency virus infection of human astrocytes disrupts bloodbrain barrier integrity by a gap junction-dependent mechanism. J Neurosci 2011;31:9456-65.
48. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 2007;13:1173-5.
49. Welsher K, Yang H. Multi-resolution 3D visualization of the early stages of cellular uptake of peptide-coated nanoparticles. Nat Nanotechnol. Nature Publishing Group; 2014;9:198-203.
50. Nienhaus K, Ulrich Nienhaus G. Fluorescent proteins for live-cell imaging with super-resolution. Chem Soc Rev 2014;43:1088-106.
51. Yun S-W, Kang N-Y, Park S-J, Ha H-H, Kim YK, Lee J-S, et al. Diversity oriented fluorescence library approach (DOFLA) for live cell imaging probe development. Acc Chem Res. American Chemical Society; 2014;47:1277-86.
52. Burchfield JG, Lopez JA, Mele K, Vallotton P, Hughes WE. Exocytotic vesicle behaviour assessed by total internal reflection fluorescence microscopy. Traffic 2010;11:429-39.
53. Millis BA. Evanescent-wave field imaging: An introduction to total internal reflection fluorescence microscopy. Methods Mol Biol 2012;823:295-309.
54. Mattheyses AL, Simon SM, Rappoport JZ. Imaging with total internal reflection fluorescence microscopy for the cell biologist. J Cell Sci 2010;123:3621-8.
55. Wallrabe H, Periasamy A. Imaging protein molecules using FRET and FLIM microscopy. Curr Opin Biotechnol 2005;16:19-27.
56. Walker-Daniels J. Live cell imaging methods review. Mater Methods 2012;2:124.
57. Parhamifar L, Wu L, Andersen H, Moghimi SM. Live-cell fluorescent microscopy platforms for real-time monitoring of polyplexcell interaction: basic guidelines. Methods 2014;68:300-7.
58. Hoshi Y, Uchida Y, Tachikawa M, Inoue T, Ohtsuki S, Terasaki T. Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset. J Pharm Sci 2013;102:3343-55.
59. Iversen T-G, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011;6:176-85.
60. Tuma PL, Hubbard AL. Transcytosis: crossing cellular barriers. Physiol Rev 2003;83:871-932.
61. Cucullo L, Couraud P-O, Weksler B, Romero I-A, Hossain M, Rapp E, et al. Immortalized human brain endothelial cells and flow-based vascular modeling: A marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 2008;28:312-28.
62. Booth R, Kim H. Characterization of a microfluidic in vitro model of the blood-brain barrier (BBB). Lab Chip 2012;12:1784-92.
63. Griep LM, Wolbers F, de Wagenaar B, ter Braak PM, Weksler BB, Romero IA, et al. BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 2013;15:145-50.
64. Prabhakarpandian B, Shen M-C, Nichols JB, Mills IR, Sidoryk-Wegrzynowicz M, Aschner M, et al. SyM-BBB: A microfluidic blood brain barrier model. Lab Chip 2013;13:1093-101.
65. Booth R, Noh S, Kim H. A multiple-channel, multiple-Assay platform for characterization of full-range shear stress effects on vascular endothelial cells. Lab Chip 2014;14:1880-90